150 related articles for article (PubMed ID: 34364063)
1. Serum IGF-I concentrations are low in female bodybuilders in the pre-contest phase.
Monteiro DPPF; Correa M; Neto TT; Martinelli CE; Filho HT
Growth Horm IGF Res; 2021; 60-61():101420. PubMed ID: 34364063
[TBL] [Abstract][Full Text] [Related]
2. Serum IGF-I, IGFBP-3 and ALS concentrations and physical performance in young swimmers during a training season.
Tourinho Filho H; Pires M; Puggina EF; Papoti M; Barbieri R; Martinelli CE
Growth Horm IGF Res; 2017 Feb; 32():49-54. PubMed ID: 28011098
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone induced increase in serum IGFBP-3 level is reversed by anabolic steroids in substance abusing power athletes.
Karila T; Koistinen H; Seppälä M; Koistinen R; Seppälä T
Clin Endocrinol (Oxf); 1998 Oct; 49(4):459-63. PubMed ID: 9876343
[TBL] [Abstract][Full Text] [Related]
4. Anabolic and catabolic hormones and energy balance of the male bodybuilders during the preparation for the competition.
Mäestu J; Eliakim A; Jürimäe J; Valter I; Jürimäe T
J Strength Cond Res; 2010 Apr; 24(4):1074-81. PubMed ID: 20300017
[TBL] [Abstract][Full Text] [Related]
5. Macronutrient considerations for the sport of bodybuilding.
Lambert CP; Frank LL; Evans WJ
Sports Med; 2004; 34(5):317-27. PubMed ID: 15107010
[TBL] [Abstract][Full Text] [Related]
6. IGF-I and IGFBP-1 in Relation to Body Composition and Physical Performance in Female Olympic Athletes.
Eklund E; Hellberg A; Berglund B; Brismar K; Hirschberg AL
Front Endocrinol (Lausanne); 2021; 12():708421. PubMed ID: 34484121
[TBL] [Abstract][Full Text] [Related]
7. Endurance training-induced changes in the GH-IGF-I axis influence maximal muscle strength in previously untrained men.
Grandys M; Majerczak J; Kuczek P; Sztefko K; Duda K; Zoladz JA
Growth Horm IGF Res; 2017 Feb; 32():41-48. PubMed ID: 28017505
[TBL] [Abstract][Full Text] [Related]
8. Effect of home-based strength training program on IGF-I, IGFBP-1 and IGFBP-3 in obese Latino boys participating in a 16-week randomized controlled trial.
Kelly L; Holmberg PM; Schroeder ET; Loza A; Lin X; Moody A; Hughes A; Gibson AM; Kirk A
J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1121-1129. PubMed ID: 31539362
[TBL] [Abstract][Full Text] [Related]
9. Nutritional strategies of British professional and amateur natural bodybuilders during competition preparation.
Chappell AJ; Simper T; Helms E
J Int Soc Sports Nutr; 2019 Aug; 16(1):35. PubMed ID: 31438992
[TBL] [Abstract][Full Text] [Related]
10. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
[TBL] [Abstract][Full Text] [Related]
11. Nutritional strategies of high level natural bodybuilders during competition preparation.
Chappell AJ; Simper T; Barker ME
J Int Soc Sports Nutr; 2018; 15():4. PubMed ID: 29371857
[TBL] [Abstract][Full Text] [Related]
12. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.
Wallace JD; Cuneo RC; Baxter R; Orskov H; Keay N; Pentecost C; Dall R; Rosén T; Jørgensen JO; Cittadini A; Longobardi S; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH
J Clin Endocrinol Metab; 1999 Oct; 84(10):3591-601. PubMed ID: 10523001
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
Guha N; Erotokritou-Mulligan I; Nevitt SP; Francis M; Bartlett C; Cowan DA; Bassett EE; Sönksen PH; Holt RI
Drug Test Anal; 2013; 5(11-12):843-9. PubMed ID: 24173773
[TBL] [Abstract][Full Text] [Related]
14. Alterations in serum growth hormone (GH)/GH dependent ternary complex components (IGF-I, IGFBP-3, ALS, IGF-I/IGFBP-3 molar ratio) and the influence of these alterations on growth pattern in female rhythmic gymnasts.
Adiyaman P; Ocal G; Berberoğlu M; Evliyaoğlu O; Aycan Z; Cetinkaya E; Bulca Y; Ersöz G; Akar N
J Pediatr Endocrinol Metab; 2004 Jun; 17(6):895-903. PubMed ID: 15270408
[TBL] [Abstract][Full Text] [Related]
15. Nutritional and endocrine-metabolic aberrations in amenorrheic athletes.
Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1996 Dec; 81(12):4301-9. PubMed ID: 8954031
[TBL] [Abstract][Full Text] [Related]
16. Exercise-induced insulin-like growth factor I system concentrations after training in women.
Gregory SM; Spiering BA; Alemany JA; Tuckow AP; Rarick KR; Staab JS; Hatfield DL; Kraemer WJ; Maresh CM; Nindl BC
Med Sci Sports Exerc; 2013 Mar; 45(3):420-8. PubMed ID: 23034644
[TBL] [Abstract][Full Text] [Related]
17. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
Holt RI; Jones JS; Stone NM; Baker AJ; Miell JP
J Clin Endocrinol Metab; 1996 Jan; 81(1):160-8. PubMed ID: 8550746
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
Wilson ME
J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
[TBL] [Abstract][Full Text] [Related]
19. Detraining and tapering effects on hormonal responses and strength performance.
Izquierdo M; Ibañez J; González-Badillo JJ; Ratamess NA; Kraemer WJ; Häkkinen K; Bonnabau H; Granados C; French DN; Gorostiaga EM
J Strength Cond Res; 2007 Aug; 21(3):768-75. PubMed ID: 17685721
[TBL] [Abstract][Full Text] [Related]
20. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
